Analysis of ECGio to Predict Coronary Stenosis Against a Mixed Reference Standard (NCT07375810)
A Study to Measure Underlying Coronary Stenosis; a Retrospective, Multi-center Study to Measure Efficacy of ECGio Against Multiple Reference Standards
🩺 Plain-English Summary (8th-Grade Level)
The study objective is to evaluate the effectiveness of the ECGio algorithm in predicting clinically significant coronary artery disease . ECGio's diagnostic performance during the trial will be compared against an objective performance ¬criteria using a mixed reference standard of quantitative coronary angiography and quantitative coronary computed tomography angiography in patients a general adult population under suspicion of coronary artery disease.
Who can join: Review the eligibility criteria below.
Location: Medstar Washington Hospital Center — Washington D.C., District of Columbia
Age range: 18 Years to 89 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Medstar Washington Hospital Center — Washington D.C., District of Columbia
- Cena Research Institute — Houston, Texas
📞 Contact the Study Coordinator
Phone: (610) 451-7343
Email: Michael.Leasure@heartio.ai
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Coronary Artery Disease (CAD)
- A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery. — Rochester, Minnesota
- AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease — Thousand Oaks, California
- Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG — Cincinnati, Ohio
- The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI — Marietta, Georgia
- Using CTA Measures to Define Cardiac Risk In NFL Alumni — Greenwood Village, Colorado
Explore by condition: All Coronary Artery Disease (CAD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.